Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 2Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 1Postoperative Nausea and Vomiting 1Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × ramosetron × Clear all
NCT05326360 2022-04-19

Ramosetron on Late PONV (Postoperative Nausea and Vomiting)

Pusan National University Hospital

Phase 4 Completed
144 enrolled

Postoperative Nausea and Vomiting

NCT02532634 2018-05-11

RAPA

Kangdong Sacred Heart Hospital

Phase 4 Completed
292 enrolled

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡